Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Status:
Terminated
Trial end date:
2001-04-27
Target enrollment:
Participant gender:
Summary
Current therapies for Adenocarcinoma of the Esophagus provide limited benefit to the patient.
The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in
the treatment of Adenocarcinoma of the Esophagus.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Adenocarcinoma of the Esophagus.